Development
Lexicon Pharmaceuticals, Inc.
LXRX
$1.15
$0.109.52%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.92% | 142.35% | -23.43% | 1.58% | 119.80% |
| Total Receivables | -53.58% | 162.45% | 832.14% | -28.21% | 14.71% |
| Inventory | 95.35% | -- | -- | -- | -- |
| Prepaid Expenses | -29.93% | 82.92% | 34.95% | -12.05% | -2.59% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -15.30% | 140.74% | -22.23% | 1.30% | 114.28% |
|
|
|||||
| Total Current Assets | -15.30% | 140.74% | -22.23% | 1.30% | 114.28% |
| Net Property, Plant & Equipment | -7.56% | -1.92% | -2.96% | 10.04% | 180.13% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -12.71% | 94.65% | -16.25% | 1.36% | 70.65% |
|
|
|||||
| Total Accounts Payable | 14.62% | 1.84% | -0.81% | 10.27% | 28.31% |
| Total Accrued Expenses | 32.25% | 63.27% | -23.65% | 50.89% | -12.77% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.00% | 0.00% | 0.00% | -8.18% | 78.20% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 23.56% | 28.17% | -12.09% | 25.63% | 9.39% |
|
|
|||||
| Total Current Liabilities | 23.56% | 28.17% | -12.09% | 25.63% | 9.39% |
| Long-Term Debt | 0.50% | 102.22% | 0.55% | 104.25% | 0.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.71% | 0.51% | 0.55% | -0.26% | 442.71% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.07% | 74.59% | -3.25% | 61.90% | 14.87% |
|
|
|||||
| Common Stock & APIC | 0.20% | 8.36% | 0.20% | 0.21% | 6.02% |
| Retained Earnings | -3.03% | -2.77% | -2.01% | -1.96% | -1.52% |
| Treasury Stock & Other | -0.44% | 2.07% | -22.46% | 2.47% | -15.42% |
| Total Common Equity | -25.14% | 111.66% | -24.83% | -18.67% | 103.33% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -25.14% | 111.66% | -24.83% | -18.67% | 103.33% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -25.14% | 111.66% | -24.83% | -18.67% | 103.33% |
|
|
|||||